Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
You can learn more about the benefits and risks of compounding pharmacies here
The bioavailability is high, but bioavailability is not the same as benefit
No matter where in the world I am, I am listening to music to set the tone for the day
This molecule works to neutralize free radicals
You may also like Product Description PT-141 Peptide | Buy PT-141 UK | Research Use Only PT-141 also known as Bremelanotide and Vyleesi (FDA-approved pharmaceutical formulation) is a synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, MW 1,025.2 Da) originally derived as an active metabolite of Melanotan II and engineered as a non-selective melanocortin receptor agonist with highest affinity for MC4R, acting centrally in the medial preoptic area and paraventricular nucleus of the hypothalamus to modulate dopaminergic, noradrenergic, and serotoninergic neurotransmission governing sexual desire and arousal making it the only CNS-acting melanocortin system research tool with a full Phase II and Phase III clinical evidence base, FDA approval (2019) as Vyleesi for hypoactive sexual desire disorder in premenopausal women, and a pharmacological profile mechanistically distinct from PDE5 inhibitors operating upstream on the neural circuitry of desire rather than downstream on vascular nitric oxide pathways
US$ 28.29
US$ 28.78
US$ 29.06
US$ 27.54
